AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 152 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.27 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $322,000 | -19.7% | 9,349 | -61.0% | 0.00% | -33.3% |
| Q2 2020 | $401,000 | +13.0% | 23,989 | -2.5% | 0.00% | 0.0% |
| Q1 2020 | $355,000 | -51.3% | 24,593 | +13.0% | 0.00% | -40.0% |
| Q4 2019 | $729,000 | +33.8% | 21,767 | -16.4% | 0.01% | +25.0% |
| Q3 2019 | $545,000 | +84.1% | 26,044 | +83.2% | 0.00% | +100.0% |
| Q2 2019 | $296,000 | +11.7% | 14,220 | +46.3% | 0.00% | 0.0% |
| Q3 2018 | $265,000 | -33.1% | 9,720 | -34.0% | 0.00% | -50.0% |
| Q2 2018 | $396,000 | +7.9% | 14,720 | +27.8% | 0.00% | 0.0% |
| Q1 2018 | $367,000 | +38.5% | 11,520 | +64.1% | 0.00% | +33.3% |
| Q4 2017 | $265,000 | – | 7,020 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|